NVONovo NordiskNVO info
$134.85info2.11%24h
Global rank13
Market cap$604.51B
Change 7d-1.19%
YTD Performance32.58%
SP500 benchmarkOutperform
P/E7.24
P/S17.47
Revenue$34.60B
Earnings$12.47B
Dividend yield0.8%
Main Sector
Healthcare

Novo Nordisk (NVO) Stock Overview

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

NVO Stock Information

Symbol
NVO
Address
Novo Alle 1Bagsvaerd, 2880Denmark
Founded
-
Trading hours
9:30 AM - 4:00 PM ET
Website
https://www.novonordisk.com
Country
🇩🇰 Denmark
Phone Number
45 44 44 88 88

Novo Nordisk (NVO) Price Chart

-
Value:-

Novo Nordisk Overview: Key Details and Summary

Stock data
2023
Change
Price
$134.85
N/A
Market Cap
$604.51B
N/A
Shares Outstanding
4.48B
-1.06%
Employees
61.41K
N/A
Shareholder Equity
106.56B
27.64%
Valuation
2023
Change
P/E Ratio
7.24
N/A
P/S Ratio
17.47
N/A
P/B Ratio
5.67
N/A
P/FCF
57.96
N/A
POE
0.00
N/A
Dividends
2023
Change
Dividend Yield
0.78%
N/A
Dividend per share
1.0557
N/A
Dividend Payout Ratio
0.3796
N/A
Growth
2023
Change
ROIC
0.4931
N/A
CAPEX
-3.84B
N/A
Return on Equity
0.1170
N/A
Earnings
2023
Change
Revenue
$34.60B
N/A
Earnings
$12.47B
N/A
Free Cash Flow
$10.43B
N/A
EPS
18.62
N/A
Earnings Yield
0.1381
N/A
Gross Margin
0.846
N/A
Operating Margin
0.4416
N/A
Net income margin
0.3603
N/A
FCF Margin
0.3014
N/A
Financial Strength
2023
Change
Total Assets
$46.85B
N/A
Total Debt
$4.02B
N/A
Cash on Hand
$4.50B
N/A
Debt to Equity
0.2907
3.25%
Cash to Debt
$1.12
22.43%
POE
0.0000
N/A
Current Ratio
0.8231
-7.99%
Other data
2023
Change
Buyback Yield
0.0074
N/A
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org